I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 15 studies | 22% ± 6% | |
| plasmacytoid dendritic cell | 9 studies | 21% ± 4% | |
| memory B cell | 9 studies | 23% ± 8% | |
| natural killer cell | 7 studies | 36% ± 15% | |
| CD8-positive, alpha-beta T cell | 7 studies | 30% ± 12% | |
| plasmablast | 5 studies | 43% ± 15% | |
| conventional dendritic cell | 5 studies | 30% ± 11% | |
| pro-B cell | 5 studies | 29% ± 10% | |
| T cell | 5 studies | 27% ± 8% | |
| CD4-positive, alpha-beta T cell | 5 studies | 26% ± 9% | |
| hematopoietic precursor cell | 4 studies | 38% ± 14% | |
| plasma cell | 4 studies | 38% ± 16% | |
| dendritic cell | 4 studies | 33% ± 12% | |
| naive B cell | 4 studies | 20% ± 5% | |
| exhausted T cell | 3 studies | 20% ± 5% | |
| non-classical monocyte | 3 studies | 24% ± 6% | |
| erythroblast | 3 studies | 55% ± 21% | |
| germinal center B cell | 3 studies | 25% ± 8% | |
| precursor B cell | 3 studies | 26% ± 6% | |
| erythrocyte | 3 studies | 36% ± 15% | |
| transit amplifying cell | 3 studies | 32% ± 6% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 43% ± 21% |
